Plastic knee replacement part compared with metal one for knee osteoarthritis
Tests a PEEK knee implant part against a metal one in knee osteoarthritis.
Key facts
- Who runs it
- Maxx Orthopedics Inc
- Where
- Leawood and San Antonio, United StatesSee the 2 sites
- Trial code
- Registry title
- MultiCenter IDE Study of the PEEK-OPTIMA™ Femoral Component vs a CoCr Alloy TKA Femoral Component of Similar Design
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 1 Jan 2026
- Expected to end
- 1 Mar 2029
- Type of study
- Interventional
- Treatments tested
- Total Knee Arthroplasty
- Record updated
- 26 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with severe knee osteoarthritis in one knee who will have a total knee replacement. They will get a new thigh-bone part made of PEEK plastic.
- Age
- 18 years or older
- Sex
- Men and women
- Disease stage
- End-stage knee osteoarthritis with symptoms in one knee only. Knee Society Score (KSS) Knee score must be >25 and <75 before surgery.
- Earlier treatment
- No earlier surgery on the knee to be treated, such as knee replacement, osteotomy, ligament reconstruction, fusion or fracture fixation. No knee replacement on the other knee within ±1 year of the study surgery.
Main reasons for not taking part
- Osteoporosis or a fracture caused by osteoporosis
- Current cancer, active or suspected infection, rheumatoid arthritis, lupus, or a weakened immune system
- Inflammatory or injury-related arthritis, or severe leg alignment problems (over 20 degrees)
- ASA Grade III or IV general health status
- Pregnant or breastfeeding, or in another study with a test product in the last 6 months
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- Male and female subjects 18 years of age or older
- Subjects with a primary diagnosis of end-stage symptomatic unilateral primary knee osteoarthritis
- Subjects with a pre-operative Knee Society Score (KSS) Knee score of >25 and <75
- Subjects who, in the opinion of the Investigator, can understand this clinical investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups
- Subjects who can give voluntary, written informed consent to participate in this clinical investigation and from whom consent has been obtained
Who cannot take part
- Subjects who have participated in a clinical study with an investigational product in the last 6 months
- Subjects with known osteoporosis and/or previous history of fracture related to osteoporosis
- Subjects who have previously undergone surgery on the indicated knee including total knee arthroplasty, patellofemoral arthroplasty, or unicondylar knee arthroplasty, high tibial osteotomy, ligament reconstruction, fusion, open reduction and internal fixation
- Subjects that have undergone, or scheduled to undergo, contralateral total knee arthroplasty or unicondylar knee arthroplasty within ±1 year from the study surgical procedure
- Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this clinical investigation
- Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes
- Subjects with a current or active history of malignancy, active or suspected infection, Paget's disease, renal osteodystrophy, immunologically suppressed, rheumatoid arthritis, sickle cell anemia, and systemic lupus erythematosus
- Evidence of active or suspected (systemic or local) infection at time of surgery
- Subjects with other significant disabling problems from the muscular-skeletal system other than in the knees (i.e.: muscular dystrophy, polio, neuropathic joints)
- Subjects defined by the Investigator as American Society of Anesthesiologists (ASA) Grade III or IV
- Subjects who have a neuromuscular or neurosensory deficit
- Female subjects who are pregnant or lactating
- Subjects with an anatomical limb alignment of above 20 degrees varus or valgus
- Subjects with primary or secondary diagnosis of inflammatory or traumatic arthritis
- Subjects with a fixed flexion deformity of over 20 degrees
- Subjects with recurvatum (definition: hyperextension ≥ 5 degrees)
Where in United States
- AscentisLeawood, United StatesContact: Palmisano, MDTaking people
- South Texas Bone and JointSan Antonio, United StatesContact: Nach Dave, M.S., R.Ph.Taking people
About the trial
What the trial wants to find out
The purpose of this investigational device exemption (IDE) study is to monitor the performance (safety and efficacy) of the Maxx Orthopedics, Freedom Total Knee® System, with a femoral component of similar design, manufactured from polyether-ether-ketone (PEEK).
The group in the trial
- Treatment arm utilizing primary TKA with PEEK femoral componentTreatment being tested
This study is a single arm, multi-center, prospective IDE trial. Two hundred (200) patients recruited and consented will receive the PEEK-OPTIMA™ Femoral Component and results will be compared to matched historic controls from the Maxx Orthopedics Freedom Total Knee System product registry (PK-00002 REV-01, WCG IRB# 20241890). Male and female patients 18 years of age or older with Knee Society Score (KSS) of \>25 and \<75 will be eligible for enrollment.
Treatment: Total Knee Arthroplasty
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- MultiCenter Prospective Parallel Registry Controlled Investigational Device Exemption Clinical Study to Determine Non-Inferiority of the PEEK-OPTIMA™ Femoral Component Versus a CoCr Alloy Femoral Component of Similar Design for TKA
- Plain-language title
- Plastic knee replacement part compared with metal one for knee osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 26 June 2026